IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,871 | -46.1% | 4,587 | -16.6% | 0.00% | – |
| Q2 2023 | $38,698 | +13.3% | 5,497 | -1.7% | 0.00% | – |
| Q1 2023 | $34,161 | +65.1% | 5,591 | +72.7% | 0.00% | – |
| Q4 2022 | $20,685 | -13.8% | 3,237 | +29.1% | 0.00% | – |
| Q3 2022 | $24,000 | -45.5% | 2,507 | -37.3% | 0.00% | – |
| Q2 2022 | $44,000 | -18.5% | 3,999 | +22.2% | 0.00% | – |
| Q1 2022 | $54,000 | -34.1% | 3,273 | -24.0% | 0.00% | – |
| Q4 2021 | $82,000 | -60.8% | 4,308 | -49.3% | 0.00% | – |
| Q3 2021 | $209,000 | +39.3% | 8,489 | +48.4% | 0.00% | – |
| Q2 2021 | $150,000 | +10.3% | 5,722 | +32.7% | 0.00% | – |
| Q1 2021 | $136,000 | -85.9% | 4,312 | -79.2% | 0.00% | -100.0% |
| Q4 2020 | $964,000 | +129.5% | 20,773 | +63.0% | 0.00% | +100.0% |
| Q3 2020 | $420,000 | +324.2% | 12,748 | +255.1% | 0.00% | – |
| Q2 2020 | $99,000 | -10.0% | 3,590 | -2.7% | 0.00% | – |
| Q1 2020 | $110,000 | +89.7% | 3,688 | +74.7% | 0.00% | – |
| Q4 2019 | $58,000 | +152.2% | 2,111 | +72.3% | 0.00% | – |
| Q3 2019 | $23,000 | 0.0% | 1,225 | +31.6% | 0.00% | – |
| Q2 2019 | $23,000 | – | 931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |